CRYSTEC PHARMA
CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. Our technology enables drug molecules to be crystallised in new forms and novel particles to be manufactured in ways that greatly enhance their therapeutic performance. Crystec has an enabling platform which can be applied to small and large molecules, to optimise a range of medicine dosage forms (e.g. oral, inhaled, intranasal,... subcutaneous, sublingual). Crystec works with the global pharmaceutical and health care industry to solve drug particle formation, formulation and process challenges. We are also developing our own innovative therapies in important areas of unmet clinical need, including womenโs health, urology and treating respiratory disease. Crystecโs proprietary โmSASโ (modified Supercritical Anti-Solvent) drug delivery technology is enabled by a highly efficient, stable and fully scalable manufacturing process and is approved by regulatory authorities. The mSAS platform creates unique opportunities to improve medicines in ways that can transform the quality of life for many patients.
CRYSTEC PHARMA
Industry:
Biopharma Biotechnology Health Care Manufacturing Pharmaceutical
Address:
Bradford, Somerset, United Kingdom
Country:
United Kingdom
Website Url:
http://www.crystecpharma.com
Status:
Active
Contact:
+44 (0)1274 235592
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Microsoft Exchange Online Organization Schema Office 365 Mail AJAX Libraries API
Current Employees Featured
Founder
Official Site Inspections
http://www.crystecpharma.com Semrush global rank: 760.77 K Semrush visits lastest month: 52.59 K
- Host name: grh44.myukcloud.com
- IP address: 85.92.70.80
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Crystec Pharma"
About Crystec - Crystec Limited (CrystecPharma)
About Crystec About Us CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. Our technology enables drug โฆSee details»
Crystec Pharma - Crunchbase Company Profile & Funding
CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. Our โฆSee details»
CrystecPharma - LinkedIn
CrystecPharma | 4,225 followers on LinkedIn. Performance in every particle | Crystec Pharma is focused on applying supercritical fluid technology to improve the performance of medicines. We ...See details»
Crystec Pharma - VentureRadar
CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. Our โฆSee details»
Crystec Pharma Company Profile 2024: Valuation, โฆ
Information on valuation, funding, cap tables, investors, and executives for Crystec Pharma. Use the PitchBook Platform to explore the full profile.See details»
Crystec Pharma - Craft
CrystecPharma is a company that provides crystal and particle engineering solutions to the pharmaceutical industry. It is focused on applying supercritical fluid technology to improve the โฆSee details»
How We Operate โ Crystec Limited (CrystecPharma)
Crystec is investing in the development of its own portfolio of improved or repurposed generic products. Each of these products is exploiting specific advantages of mSAS ® technology, whether in designing particles capable of โฆSee details»
CrystecPharma Ltd.: Contact Details and Business Profile
CrystecPharma Ltd. is a Pharmaceuticals, Drug Manufacturing & Research, and Biopharma company located in Bradford, England with $4.00 Million in revenue and 17 employees. Find โฆSee details»
About Us - CrystecPharma
CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. ... has โฆSee details»
Crystec Pharma | Scientist.com
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the โฆSee details»
CrystecPharma - Overview, News & Similar companies - ZoomInfo
Nov 5, 2019 CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. Our โฆSee details»
CrystecPharma | ้ข่ฑ - ้ข่ฑ (ไธญๅฝ)
CrystecPharma | ๅจ้ข่ฑไธๆ 4,031 ไฝๅ ณๆณจ่ ใPerformance in every particle | Crystec Pharma is focused on applying supercritical fluid technology to improve the performance of medicines. โฆSee details»
Our History - Crystec Limited (CrystecPharma)
Our History Crystec establishes Inhalis Therapeutics SA, a Swiss joint venture with SignalRX Pharmaceuticals and ADYA Sagl to develop a novel inhaled treatment for Idiopathic โฆSee details»
CrystecPharma - Company Profile & Staff Directory - ContactOut
Crystec Pharma is focused on applying supercritical fluid technology to improve the performance of medicines. We provide crystal and particle engineering solutions to the pharmaceutical โฆSee details»
CrystecPharma Company Overview, Contact Details & Competitors โฆ
Industry Recognition The recognition received by CrystecPharma, such as the Making Pharmaceuticals Award for Innovation in Manufacturing, showcases the company's โฆSee details»
A collaboration to enhance the delivery of biotherapeutics and โฆ
Oct 19, 2021 www.crystecpharma.com For further information please contact: - Emily Bevis, Business Development Manager ([email protected]) - Angeles Heer, Tech โฆSee details»
Solutions โ Crystec Limited (CrystecPharma)
40% of marketed drugs and up to 90% of those in development exhibit poor solubility. mSAS ® provides different ways to address this challenge, including through increasing surface area, โฆSee details»
Collaboration Between CrystecPharma and Iconovo Aims to โฆ
Nov 8, 2019 CrystecPharma specializes in a technique called modified supercritical anti-solvent (mSAS) technology to engineer particles with improved characteristics. In mSAS, the โฆSee details»
Pipeline - Crystec Limited (CrystecPharma)
Crystec Development Pipeline In addition to enhancing the performance of client products, we also apply our mSAS® technology platform in non-competing areas to Crystecโs own in-house โฆSee details»